ArticleFrontiers in genetics2022
The multidimensional legal nature of personal genomic sequence data: A South African perspective.
Article in Frontiers in genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Cultivating an equity-oriented data sharing culture for African health research initiatives.Nature communications · 2025Article
- OWNERSHIP OF PERSONAL INFORMATION?South African law journal · 2025Article
- Forcing a square into a circle: why South Africa's draft revised material transfer agreement is not fit for purpose.Frontiers in pharmacology · 2024Article
- A pathway to strengthening open science: comments on the draftFrontiers in pharmacology · 2024Review
- The open ontology and information society.Frontiers in genetics · 2024Article
- The anatomy of a data transfer agreement for health research.Frontiers in pharmacology · 2024Article
- Editorial: Data governance in African health research: ELSI challenges and solutions.Frontiers in pharmacology · 2024Article
- The proposed Code of Conduct for Research in South Africa: despite good progress, unresolved issues remain.Humanities & social sciences communications · 2024Article
- Towards a data transfer agreement for the South African research community: The empowerment approach.South African journal of bioethics and law · 2023Article
- Toward an open access genomics database of South Africans: ethical considerations.Frontiers in genetics · 2023Article
- Regulating human genomic research in Africa: why a human rights approach is a more promising conceptual framework than genomic sovereignty.Frontiers in genetics · 2023Article
- Open science and human genetic data: recommendations on South Africa'sFrontiers in genetics · 2023Article
- The human genome as the common heritage of humanity.Frontiers in genetics · 2023Article
- A data management plan for the NESHIE observational study.Frontiers in genetics · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
This article provides a comprehensive analysis of the various dimensions in South African law applicable to personal genomic sequence data. This analysis includes property rights, personality rights, and intellectual property rights. Importantly, the under-investigated question of whether personal genomic sequence data are capable of being owned is investigated and answered affirmatively. In addition to being susceptible of ownership, personal genomic sequence data are also the object of data subjects' personality rights, and can also be the object of intellectual property rights: whether on their own
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.